medi-cal no longer covering glp-1 California's Proposal to Cut Coverage for Medicare to cover GLP-1 drugs
Description
This is because undetectable in a small study is not the same as a guarantee of safety for everyone
They do accept HSA and FSA funds
Ascendis Pharma A/S granted Novo Nordisk A/S exclusive global rights to its TransCon technology for the development, manufacturing, and commercialisation of Novo Nordisk products aimed at metabolic diseases, including obesity and type 2 diabetes, along with select cardiovascular applications
There is limited evidence that supplements like berberine, fiber, and probiotics may help raise GLP-1 in the body
In late 2024, the FDA lifted the shortage designation for tirzepatide and directed compounders to cease production
Who makes Trulicity
